Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor beta.
Open Access
- 1 January 1990
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 171 (1) , 231-247
- https://doi.org/10.1084/jem.171.1.231
Abstract
We describe here the isolation and sequencing of a previously uncharacterized HLA class I gene. This gene, HLA-5.4, is the third non-HLA-A,B,C gene characterized whose sequence shows it encodes an intact class I protein. RNase protection assays with a probe specific for this gene demonstrated its expression in B lymphoblastoid cell lines, in resting T cells, and skin cells, while no mRNA could be detected in the T cell line Molt 4. Consistent with a pattern of expression different from that of other class I genes, DNA sequence comparisons identified potential regulator motifs unique to HLA-5.4 and possibly essential for tissue-specific expression. Protein sequence analysis of human and murine class I antigens has identified 10 highly conserved residues believed to be involved in antigen binding. Five of these are altered in HLA-5.4, and of these, three are nonconservative. In addition, examination of the HLA-5.4 DNA sequence predicts that the cytoplasmic segment of this protein is shorter than that of the classical transplantation antigens. The 3' untranslated region of the HLA-5.4 gene contains one member of a previously undescribed multigene family consisting of at least 30 members. Northern analysis showed that several of these sequences were transcribed, and the most ubiquitous transcript, a 600-nucleotide polyadenylated mRNA, was found in all tissues and cells examined. This sequence is conserved in the mouse genome, where a similar number of copies were found, and one of these sequences was also transcribed, yielding a 600-nucleotide mRNA. The characterization of this unique HLA class I gene and the demonstration of its tissue-specific expression have prompted us to propose that HLA-5.4 be designated HLA-F.This publication has 38 references indexed in Scilit:
- Transforming growth factor-beta (TGFβ) is chemotactic for human monocytes and induces their expression of angiogenic activityPublished by Elsevier ,2005
- Transforming growth factor-beta production by synovial tissues from rheumatoid patients and streptococcal cell wall arthritic rats. Studies on secretion by synovial fibroblast-like cells and immunohistologic localization.The Journal of Immunology, 1989
- Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye.Journal of Clinical Investigation, 1989
- Binding of Transforming Growth Factor-β to Cell Surface Proteins Varies with Cell TypeMolecular Endocrinology, 1989
- Active and latent forms of transforming growth factor beta activity in synovial effusions.The Journal of Experimental Medicine, 1989
- PRODUCTION OF TUMOR NECROSIS FACTOR BY RIFN-GAMMA-PRIMED C3H-HEJ (LPSD) MACROPHAGES REQUIRES THE PRESENCE OF LIPID A-ASSOCIATED PROTEINS1988
- Bacterial cell wall-induced immunosuppression. Role of transforming growth factor beta.The Journal of Experimental Medicine, 1988
- Cartilage-inducing factor-B is a unique protein structurally and functionally related to transforming growth factor-beta.Journal of Biological Chemistry, 1987
- Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta.The Journal of Experimental Medicine, 1987
- Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes.The Journal of Immunology, 1986